Trps1 Differentially Modulates the Bone Mineral Density between Male and Female Mice and Its Polymorphism Associates with BMD Differently between Women and Men
The objective of our study was to identify genetic factors that regulate bone mineral density (BMD) in mice using well defined recombinant inbred strains. For this purpose we chose the BXD recombinant inbred (RI) strains derived from progeny of the C57BL/6J (B6) and DBA/2J (D2) progenitor strains. We sampled both male and female mice (~4 each) of 46 strains at 3 months-of-age, measured their BMD, and conducted QTL mapping. The data were analyzed to identify candidates genes contained within the most significant quantitative trait locus (QTL). Evaluation of candidate genes included functional assessment, single nucleotide polymorphism (SNP) genotyping and direct sequencing. We established that there was a QTL for BMD in males on chromosome 15 that has the impact larger than QTLs on all other chromosomes. The QTL on chromosome 15 was narrowed to a genomic region between 38 Mbp and 52 Mbp. By examining transcripts within this region, we found an important candidate gene: trichorhinophalangeal syndrome, type I (Trps1). SNP analysis identified a nonsynonymous SNP (rs32398060) in Trps1 that co-segregated with bone mineral density. Analysis of association between this SNP within TRPS1 and BMD in a human population confirmed its significance.
References
[1]
Xiong Q, Jiao Y, Hasty KA, Canale ST, Stuart JM, et al. (2009) Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse. Genomics 93(5): 401–414 doi: 10.1016/j.ygeno.2008.12.008. Epub 2009 Jan 14.
[2]
Garnero P, Delmas PD (2004) Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women. J Musculoskelet Neuronal Interact 4(1): :50–63. Review.
[3]
Tremollieres F, Ribot C (2010) Bone mineral density and prediction of non-osteoporotic disease. Maturitas 65(4): 348–351 doi: 10.1016/j.maturitas.2009.12.023. Epub 2010 Jan 15.
[4]
Bonjour JP, Theintz G, Law F, Slosman D, Rizzoli R (1994) Peak bone mass. Osteoporos Int 4 Suppl 17–13.
[5]
Schnitzler CM (1993) Bone quality: a determinant for certain risk factors for bone fragility. Calcif Tissue Int 53 Suppl 1S27–31.
[6]
Jiao Y, Jin X, Yan J, Zhang C, Jiao F, et al. (2008) A deletion mutation in Slc12a6 is associated with neuromuscular disease in gaxp mice. Genomics 91(5): 407–414 doi: 10.1016/j.ygeno.2007.12.010. Epub 2008 Mar 14.
[7]
Milner LC, Buck KJ (2010) Identifying quantitative trait loci (QTLs) and genes (QTGs) for alcohol-related phenotypes in mice. Int Rev Neurobiol 91: 173–204 doi: 10.1016/S0074-7742(10)91006-4. Review.
[8]
Li GH, Cheung CL, Xiao SM, Lau KS, Gao Y, et al. (2011) Identification of QTL genes for BMD variation using both linkage and gene-based association approaches. Hum Genet 130(4): 539–546 doi: 10.1007/s00439-011-0972-2. Epub 2011 Mar 19.
[9]
Grubb SC, Churchill GA, Bogue MA (2004) A collaborative database of inbred mouse strain characteristics. Bioinformatics 20(16):2857–2859. Epub 2004 May 6.
[10]
Peirce JL, Lu L, Gu J, Silver LM, Williams RW (2004) A new set of BXD recombinant inbred lines from advanced intercross populations in mice. BMC Genet 29 5: 7.
[11]
Klein RF, Mitchell SR, Phillips TJ, Belknap JK, Orwoll ES (1998) Quantitative trait loci affecting peak bone mineral density in mice. J Bone Miner Res 13: 1648–1656.
[12]
Orwoll ES, Belknap JK, Klein RF (2001) Gender specificity in the genetic determinants of peak bone mass. J Bone Miner Res 16: 1962–1971.
[13]
Andreux PA, Williams EG, Koutnikova H, Houtkooper RH, Champy MF, et al. (2012) Systems genetics of metabolism: the use of the BXD murine reference panel for multiscalar integration of traits. Cell 150(6): 1287–1299 doi: 10.1016/j.cell.2012.08.012. Epub 2012 Aug 30.
[14]
Suwanwela J, Farber CR, Haung B, Song B, Pan C, et al. (2011) Systems genetics analysis of mouse chondrocyte differentiation. Journal of Bone and Mineral Research 26: 746–760.
[15]
Lynch RM, Naswa S, Rogers Jr GL, Kanla SA, Das S, et al. (2010) Identifying genetic loci and spleen gene coexpression networks underlying immunophenotypes in the BXD recombinant inbred mice. Physiological Genomics 41: 244–253.
[16]
Chesler EJ, Lu L, Shou S, Qu Y, Gu J, et al. (2005) Genetic dissection of gene expression reveals polygenic and pleiotropic networks modulating brain structure and function. Nature Genetics 37: 233–242.
[17]
Soon G, Quintin A, Scalfo F, Antille N, Williamson G, et al.. (2006) PIXImus bone densitometer and associated technical measurement issues of skeletal growth in the young rat. Calcif Tissue Int 78:186–192. Epub 2006 Mar 17.
[18]
Ishimori N, Stylianou IM, Korstanje R, Marion MA, Li R, et al. (2008) Quantitative trait loci for BMD in an SM/J by NZB/BlNJ intercross population and identification of Trps1 as a probable candidate gene. J Bone Miner Res 23: 1529–1537.
[19]
Xiong Q, Qiu Y, Gu W (2008) PGMapper: a web-based tool linking phenotype to genes. Bioinformatics 24: 1011–1013.
[20]
Geisert EE, Lu L, Freeman-Anderson NE, Templeton JP, Nassr M, et al. (2009) Gene expression in the mouse eye: an online resource for genetics using 103 strains of mice. Mol Vis 15: 1730–63.
[21]
Wang J, Williams RW, Manly KF (2003) WebQTL: web-based complex trait analysis Wang J, Williams RW, Manly KF. Neuroinformatics. 1(4): 299–308.
[22]
Calabrese G, Bennett BJ, Orozco L, Kang HM, Eskin E, et al.. (2012) Systems genetic analysis of osteoblast-lineage cells. PLoS Genet 8(12):e1003150. PMID: 23300464.
[23]
Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson BV, Hsu YH, et al. (2009) Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 41: 1199–206.
[24]
Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, Ntzani EE, et al. (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44: 491–501.
[25]
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559–575.
[26]
Liu EY, Li M, Wang W, Li Y (2013) MaCH-admix: genotype imputation for admixed populations. Genet Epidemiol 37: 25–37.
[27]
Pei YF, Zhang L, Liu Y, Li J, Shen H, et al.. (2013) Meta-analysis of genome-wide association data identifies novel susceptibility loci for obesity. Hum Mol Genet. PMID: 24064335.
[28]
Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34: 816–34.
[29]
Zhang L, Li J, Pei YF, Liu Y, Deng HW (2009) Tests of association for quantitative traits in nuclear families using principal components to correct for population stratification. Ann. Hum Genet 73: 601–13.
[30]
Devlin B, Roeder K (1999) Genomic control for association studies. Biometrics 55: 997–1004.
[31]
Willer CJ, Li Y, Abecasis GR (2010) METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26: 2190–1.
Ackert-Bicknell CL, Demissie S, Tsaih SW, Beamera WG, Cupples LA, et al.. (2012) Genetic variation in TRPS1 may regulate hip geometry as well as bone mineral density. Bone [Epub ahead of print]
[34]
Beamer WG, Shultz KL, Churchill GA, Frankel WN, Baylink DJ, et al. (1999) Quantitative trait loci for bone density in C57BL/6J and CAST/EiJ inbred mice. Mamm Genome 10: 1043–1049.
[35]
Yu H, Mohan S, Edderkaoui B, Masinde GL, Davidson HM, et al.. (2007) Detecting novel bone density and bone size quantitative trait loci using a cross of MRL/MpJ and CAST/EiJ inbred mice. Calcif Tissue Int 80:103–110. Epub 2007 Feb 2.
[36]
Noltorp S, Kristoffersson UL, Mandahl N, Stigsson L, Svensson B, et al. (1986) Trichorhinophalangeal syndrome type I: symptoms and signs, radiology and genetics. Ann Rheum Dis 45: 31–36.
[37]
Carrington PR, Chen H, Altick JA (1994) Trichorhinophalangeal syndrome, type I. J Am Acad Dermatol. 31: 331–336.
[38]
Sarafoglou K, Moassesfar S, Miller BS (2010) Improved growth and bone mineral density in type I trichorhinophalangeal syndrome in response to growth hormone therapy. Clin Genet 78: 591–593 doi: 10.1111/j.1399-0004.2010.01434.x.
[39]
Tariq M, Ahmad S, Ahmad W (2008) A novel missense mutation in the TRPS1 gene underlies trichorhinophalangeal syndrome type III. Br J Dermatol. 159:476–478. Epub 2008 Jun 9.
[40]
Rossi A, Devirgiliis V, Panasiti V, Borroni RG, Carlesimo M, et al.. (2007) Missense mutation in exon 7 of TRPS1 gene in an Italian family with a mild form of trichorhinophalangeal syndrome type I. Br J Dermatol 157:1021–1024. Epub 2007 Sep 13.
[41]
Vaccaro M, Guarneri F, Barbuzza O, Gaeta M, Guarneri C (2009) A familial case of trichorhinophalangeal syndrome type I. Pediatr Dermatol 26: 171–175.
[42]
Kolta S, De Vernejoul MC, Meneton P, Fechtenbaum J, Roux C (2003) Bone mineral measurements in mice: comparison of two devices. J Clin Densitom 6(3): 251–258.
